0
Epizyme Inc
- 51-200 Employees
- Based in Cambridge, Massachusetts
Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methyltransferases (HMTs).
Epizyme Inc
Most Recent Responsibility Report
MOST RECENT
Request Information
Epizyme Inc does not currently have any reports on ResponsibilityReports.co.uk. Click the button below to be notified when financial info becomes available.
Our service enables potential investors to review the most recent and archived Epizyme Inc Sustainability Report, Epizyme Inc Corporate Social Responsibility Report, Epizyme Inc CSR Report, Epizyme Inc Corporate Responsibility, Epizyme Inc CR Report, Epizyme Inc Citizenship Report, Epizyme Inc ESG Report, and Epizyme Inc Environmental Report online.